Nathan BartlettA/Prof Bartlett trained as a virologist, first at the University of Oxford and then at Imperial College London. It was at Imperial, based in the National Heart and Lung Institute, that his research became squarely focused on the disease burden associted with rhinovirus infections. At that time pre-clinical models of rhinovirus infection and disease were limited so much of his research was devoted to addressing this deficit. This led to development of in vivo rhinovirus infection models that are now an essential research tool for rhinovirus research worldwide. Following his return to Australia he accepted an academic appointment at the University of Newcastle and formed the Viral Immunology and Respiratory Disease group, based at the Hunter Medical Research Institute (Newcastle, Australia). Since that time A/Prof Bartlett has consolidated his position as an internationally recognised expert on rhinovirus pre-clinical models and disease mechanisms and is currently involved in development and commercialisation of multiple new therapies aimed at preventing the plethora of diseases caused by rhinovirus infections. He is also an associate editor for the American Journal of Physiology - Lung Molecular and Cellular Physiology and member of the College of Experts for the European Respiratory Society. Read More Read Less